Generic Injectables Market to reach a value of US$ 1.5 Bn by 2025-end | Pfizer, Inc., Novartis AG (Sandoz International GmbH), Baxter
In recent years, demand for generic drugs has seen a prolific rise. High developmental and investment costs associated with branded formulations has prompted key players [read full press release…]